Correlation Between Grace Therapeutics, and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Grace Therapeutics, and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grace Therapeutics, and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grace Therapeutics, and Vincerx Pharma, you can compare the effects of market volatilities on Grace Therapeutics, and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grace Therapeutics, with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grace Therapeutics, and Vincerx Pharma.

Diversification Opportunities for Grace Therapeutics, and Vincerx Pharma

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Grace and Vincerx is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Grace Therapeutics, and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Grace Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grace Therapeutics, are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Grace Therapeutics, i.e., Grace Therapeutics, and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Grace Therapeutics, and Vincerx Pharma

Given the investment horizon of 90 days Grace Therapeutics, is expected to generate 0.57 times more return on investment than Vincerx Pharma. However, Grace Therapeutics, is 1.75 times less risky than Vincerx Pharma. It trades about 0.04 of its potential returns per unit of risk. Vincerx Pharma is currently generating about 0.02 per unit of risk. If you would invest  210.00  in Grace Therapeutics, on September 3, 2024 and sell it today you would earn a total of  126.00  from holding Grace Therapeutics, or generate 60.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Grace Therapeutics,  vs.  Vincerx Pharma

 Performance 
       Timeline  
Grace Therapeutics, 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Grace Therapeutics, are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Grace Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Grace Therapeutics, and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Grace Therapeutics, and Vincerx Pharma

The main advantage of trading using opposite Grace Therapeutics, and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grace Therapeutics, position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Grace Therapeutics, and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets